Format

Send to

Choose Destination
Drug Discov Today. 2014 Nov;19(11):1775-1780. doi: 10.1016/j.drudis.2014.06.019. Epub 2014 Jun 25.

Crowdfunding drug development: the state of play in oncology and rare diseases.

Author information

1
Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, 4th Floor, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
2
Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, 4th Floor, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; Centre for Health Evaluation & Outcome Sciences, 588-1081 Burrard Street, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada. Electronic address: larry.lynd@ubc.ca.

Abstract

In this article, we present descriptive data on 125 crowdfunding campaigns aimed at financing research in oncology (including basic research, drug discovery, and clinical trials). We also describe five campaigns that have succeeded in raising substantial funds to support the development of treatments for ultrarare diseases. The data suggest that crowdfunding is a viable approach to supporting early proof-of-concept research that could allow researchers in oncology and rare diseases to succeed in traditional grant competitions or to attract private investment. The data also suggest that such an approach could become a valuable additional source of funding for early-stage innovators in the drug development arena.

PMID:
24973645
DOI:
10.1016/j.drudis.2014.06.019
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center